Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis

View source ↗

Summary

This ongoing clinical trial aims to evaluate the efficacy and safety of combining telitacicept with tofacitinib in patients with refractory rheumatoid arthritis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telitacicept
  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Telitacicept, Treatment Compliance | Status: RECRUITING